Article info
PDFOriginal research
Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
- Correspondence to Dr Leen Verleye, Belgian Health Care Knowledge Centre, Brussel, 1000, Belgium; leen.verleye{at}kce.fgov.be
Citation
Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
Publication history
- Received July 7, 2022
- Accepted December 12, 2022
- First published January 5, 2023.
Online issue publication
April 03, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.